David Ouyang

Real talk, let me break down David Ouyang – dude’s the real deal in the medtech world. So, he’s part of YC’s S22 batch, right? But what’s crazy is his process. He’s not just some guy who jumped into startups. Nah, he’s legit been deep in the medical game for a minute. Started out with a stats degree at Rice – so he’s got that nerdy analytical brain – then went all in on medicine with an MD from UCSF. Guy’s been through the trenches: residency and fellowship in cardiology at Stanford, one of the top spots.

He’s worked as an attending cardiologist at Cedars Sinai, which is a huge deal, and now he’s still doing his thing at Santa Clara Homestead and Kaiser Northern California. Plus, he’s an adjunct prof at Cedars-Sinai’s Smidt Heart Institute. Basically, he’s been on false equivalence of the fence – research, clinical work, teaching – you name it.

What really sets him apart is his focus on using AI and deep learning to fight heart disease. His research? Next level. He’s published in Nature, JAMA Cardiology, all the big names. His team at InVision Medical is crushing it, building AI tools to diagnose all kinds of heart issues – heart failure, amyloidosis, hypertrophic cardiomyopathy, aortic stenosis. They’re not just dreaming; they’re actually trying to get FDA clearance and run clinical trials. That’s huge.

And here’s the kicker: David isn’t just about tech for tech’s sake. He’s all-in on rapid iteration, clinical deployment, working shoulder-to-shoulder with hospitals. Dude’s been both a researcher and an entrepreneur, so he knows how to bridge the gap between science and real-world impact. That’s what makes him the real deal – he’s not just talking about the future of medicine; he’s out here building it.

Bottom line? David Ouyang is a mix of genius doctor, tech innovator, and relentless builder. He’s pushing AI into the heart of medicine, saving lives, and proving that combining deep research with startup hustle can actually change the game. No cap.